PTP
IBB icon

Platform Technology Partners’s iShares Biotechnology ETF IBB Stock Holding History

Platform Technology Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Hold
1,492
– – 0.05% 264
2025
Q4 		$252K Buy
+1,492
New +$242K 0.05% 214

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Platform Technology Partners's IBB Position: Q1 2026 in Review

Platform Technology Partners held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,492 shares worth $252K. The position accounts for 0.05% of the portfolio, ranked #264.

Platform Technology Partners first reported a position in IBB in Q4 2025 and has held it in 2 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Platform Technology Partners held 1,492 shares of iShares Biotechnology ETF worth $252K as of Q1 2026.
  • Platform Technology Partners left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.05% of Platform Technology Partners's portfolio in Q1 2026, its #264 holding.
  • Platform Technology Partners first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Platform Technology Partners's 13F filing for Q1 2026, filed 27 Apr 2026.